The Board approves the following Round 9 proposals recommended for funding by the Independent Appeal Panel in its report dated 8 February 2010, subject to paragraph 2 below:
Pakistan (HIV disease component only) – USD 11,856,124; and
Ukraine (Tuberculosis) – USD 34,584,205.
These Appeal Panel-recommended Round 9 proposals are approved for funding by the Board as ‘Category 2’ proposals, for an initial two years, under the terms of the Comprehensive Funding Policy and subject to the following:
Satisfactory completion by the applicants of the Technical Review Panel (TRP) clarifications as set out in paragraph 3 below;
the measures associated with funding of Round 9 proposals and national strategy applications set out in Decision GF/B20/DP9; and
The clear understanding that the amounts indicated are upper ceilings subject to adjustment through TRP clarifications and grant negotiations, rather than final approved Phase 1 grant amounts.
The applicants for the proposals referred to in paragraph 1 above shall:
provide an initial detailed written response to the clarifications and adjustments requested by the Independent Appeal Panel not later than six weeks after the receipt of either:
notification in writing by the Secretariat to the applicant of this Board decision; or
the findings of the independent budget review (in the case where the Independent Appeal Panel has requested an independent budget review as part of the clarifications process); and
complete any further clarifications or adjustments, as required by the Chair or Vice-Chair of the TRP, not later than three months from the Secretariat’s receipt of the applicant’s initial detailed response to the issues raised for clarifications or adjustments (if applicable).
The Board notes the Independent Appeal Panel’s request to have additional Financial analysis support as part of the clarifications process and requests the Secretariat to make the necessary arrangements.
The budgetary implications of this decision are estimated at approximately USD 25,000 for professional fees associated with the independent budget review.